Table 3.
Harrell’s c-statistic for discrimination ability of Cox proportional hazards models on 3-year overall survival of women aged 50+ years with ER-positive EIBC by country of diagnosis
| Model no. | Factors included in the cox regression model for 3 year survival | Harrell’s c-statistic for cox proportional hazards survival model | |||||
| England (internal validation) | Wales (external validation) | ||||||
| In all women* | In women who did receive surgery | In women who did not receive surgery | In all women* | In women who did receive surgery | In women who did not receive surgery | ||
| 1 | Invasive grade, T stage, N stage, HER2 status, IMD status (+receipt of surgery*) |
0.804 | 0.669 | 0.552 | 0.782 | 0.634 | 0.653 |
| 2 | Invasive grade, T stage, N stage, HER2 status, IMD status+CCI (+receipt of surgery*) | 0.824 | 0.708 | 0.618 | 0.802 | 0.664 | 0.679 |
| 3 | Invasive grade, T stage, N stage, HER2 status, IMD status+SCARF index (+receipt of surgery*) | 0.828 | 0.718 | 0.625 | 0.804 | 0.667 | 0.691 |
| 4 | Invasive grade, T stage, N stage, HER2 status, IMD status+CCI+SCARF index (+receipt of surgery*) | 0.829 | 0.719 | 0.628 | 0.805 | 0.673 | 0.690 |
| 5 | Invasive grade, T stage, N stage, HER2 status, IMD status+age (+receipt of surgery*) | 0.842 | 0.750 | 0.638 | 0.837 | 0.723 | 0.703 |
| 6 | Invasive grade, T stage, N stage, HER2 status, IMD status+CCI+SCARF index+age (+receipt of surgery*) | 0.852 | 0.770 | 0.663 | 0.841 | 0.734 | 0.715 |
*The receipt of surgery was only factored in the model that included all women.
CCI, Charlson Comorbidity Index; EIBC, early invasive breast cancer; HER2, Human epidermal growth factor receptor 2; IMD, Index for multiple deprivation; SCARF, secondary care administrative records frailty.